Conjugated Estrogens / Medroxyprogesterone Uses, Dosage, Side Effects and Interactions
Prempro
Prempro was the first conjugated estrogens / medroxyprogesterone product the FDA approved, in November 1995. No generic is listed as tablets.
Premphase
Premphase is a brand of conjugated estrogens / medroxyprogesterone that the FDA lists as a kit: the medicine packed with what is needed to prepare or give it.
Conjugated estrogens plus medroxyprogesterone is a combined estrogen and progestin hormone therapy for women with a uterus, used to treat moderate to severe menopause symptoms (hot flashes and vaginal changes) and to prevent postmenopausal osteoporosis.
Quick links
Ask Anything About Conjugated Estrogens / MedroxyprogesteroneType a question in your own words. Answered from its FDA label in seconds.Every other section of this page is in the dots on the left edge of your screen: point at one to see where it goes.Every other section of this page is one tap away: use the arrow tab on the left edge of your screen.
Conjugated Estrogens / Medroxyprogesterone in Short
- Drug classes Estrogen; Progestin How the FDA classifies it
What it treatsPrempro is an estrogen plus progestin medicine for women who still have a uterus. It treats moderate to severe vasomotor symptoms due to menopause (hot flashes and night sweats). It also treats moderate to severe vulvar and vaginal atrophy due to menopause (thinning and dryness of vaginal tissue).
- How you get it Prescription only
- Comes asTablet (by mouth)Available strengths
- ESTROGENS, CONJUGATED 0.3 mg/1; MEDROXYPROGESTERONE ACETATE 1.5 mg
- ESTROGENS, CONJUGATED 0.45 mg/1; MEDROXYPROGESTERONE ACETATE 1.5 mg
- ESTROGENS, CONJUGATED 0.625 mg/1; MEDROXYPROGESTERONE ACETATE 2.5 mg
- ESTROGENS, CONJUGATED 0.625 mg/1; MEDROXYPROGESTERONE ACETATE 5 mg
- The FDA’s strongest warningBoxed warning The FDA’s most serious alert. Read what it says
- What pharmacies pay
- Prempro (brand)$8.67 to $8.68 a tablet
The Pharmacist’s Take
Prempro combines conjugated estrogens, which replace estrogen lost after menopause, with medroxyprogesterone, a progestin that protects the uterine lining, to treat moderate to severe hot flashes and vaginal dryness and prevent bone loss in women with a uterus; it is a long-familiar, brand-only hormone therapy, marketed for over two decades. Most women tolerate it reasonably well; breast tenderness, headache, nausea and spotting are what people notice. It carries a boxed warning for blood clots, stroke, heart attack, invasive breast cancer and probable dementia, and is not meant to prevent heart disease or dementia. Use the lowest dose for the shortest time, and revisit the need regularly.
Key Takeaways From the HelloPharmacist Team
- Take Prempro once a day; Premphase uses maroon tablets for days 1 to 14, then light-blue for days 15 to 28.
- Spotting often settles over the first few months, but report vaginal bleeding that keeps coming back or has no clear cause.
- Get emergency help for sudden chest pain, trouble breathing, leg pain or swelling, sudden vision loss or signs of a stroke.
- Keep up yearly breast exams, monthly self-checks and mammograms, and report any new lump or breast change promptly.
FDA Boxed WarningThe FDA’s strongest safety alert. Read what it says about Conjugated Estrogens / Medroxyprogesterone.
This medicine can raise your risk of blood clots, stroke, heart attack, invasive breast cancer and probable dementia. In a large study of women aged 50 to 79, estrogen plus progestin increased deep vein thrombosis, pulmonary embolism, stroke and heart attack. Dementia risk rose in women 65 and older. It is unknown whether this applies to younger women.
It should not be used to prevent heart disease or dementia. Estrogen without a progestin raises the risk of endometrial (uterine lining) cancer in women with a uterus. Adding a progestin lowers the risk of the lining overgrowth that can lead to it. Use the lowest effective dose for the shortest time that fits your goals.
Patient Information Guide for Conjugated Estrogens / Medroxyprogesterone
What It’s Used For
This combination hormone therapy is for women with a uterus. The label covers:
- Prempro: treats moderate to severe vasomotor symptoms (hot flashes) due to menopause.
- Prempro: treats moderate to severe vulvar and vaginal atrophy due to menopause.
- Prempro: prevents postmenopausal osteoporosis.
How It Works
Estrogen binds to estrogen receptors in tissues throughout the body. After menopause, the body makes much less estrogen, and this medicine supplies some of it. Estrogen also lowers the elevated LH and FSH hormone levels seen after menopause.
Medroxyprogesterone is a progestin that helps protect the uterine lining. It does this partly by reducing estrogen receptors there and slowing the growth of lining cells.
Drug Class
Drug Class
- Estrogen from estrogens, conjugated (USP)
- Progestin from medroxyprogesterone
Detailed classifications and sources
The FDA sorts a drug’s active ingredient by how it works, what it does in the body and its chemical structure, and gives it one main drug class. Conjugated Estrogens / Medroxyprogesterone has two active ingredients, so each class says which one it comes from.
Drug Class
Established Pharmacologic Class (EPC)- Estrogen from estrogens, conjugated (USP)
- Progestin from medroxyprogesterone
The main drug class the FDA gives it. It is the class named on the drug’s label.
How It Works
Mechanism of action (MoA)- Estrogen Receptor Agonists from estrogens, conjugated (USP)
What it does at the smallest level, such as a receptor or enzyme it blocks or switches on.
What It Does in the Body
Physiologic effect (PE)None listed for Conjugated Estrogens / Medroxyprogesterone in the FDA’s index.
From our Patient Information GuideEstrogen binds to estrogen receptors in tissues throughout the body. After menopause, the body makes much less estrogen, and this medicine supplies some of it. Estrogen also lowers the elevated LH and FSH hormone levels seen after menopause. Medroxyprogesterone is a progestin that helps protect the uterine lining. It does this partly by reducing estrogen receptors there and slowing the growth of lining cells. Read How Conjugated Estrogens / Medroxyprogesterone Works
A change it makes in how the body works.
Chemical Family
Chemical structure (CS)- Estrogens, Conjugated (USP) from estrogens, conjugated (USP)
- Progesterone Congeners from medroxyprogesterone
The chemical family it belongs to, by its structure.
Drug Family
WHO ATC classification- Natural and semisynthetic estrogens, plain from estrogens, conjugated (USP)
- Progestogens from medroxyprogesterone
- Pregnen (4) derivatives from medroxyprogesterone
How the World Health Organization groups it: by the part of the body it acts on and what it treats.
The classes are the FDA’s own words, from its index of drug labels, published in the National Library of Medicine’s RxClass. The description under What It Does in the Body is written by the HelloPharmacist team, not the FDA. Read the FDA’s definitions. The drug family is the World Health Organization’s ATC classification. Reference only, not medical advice.
Dosage
Prempro is taken by mouth as one tablet once daily. Each tablet has both hormones.
Your prescriber should choose the lowest effective dose for the shortest time and recheck regularly whether you still need it.
Follow your prescriber's directions and your pharmacy label.
Typical Doses
Your prescriber chooses your dose, so take it exactly as prescribed.
Hot flashes and night sweats from menopause
Women with a uterus, taking Premphase Dose 0.625 mg daily
- One maroon 0.625 mg CE tablet taken daily on days 1 through 14 and one light-blue tablet containing 0.625 mg CE and 5 mg MPA taken on days 15 through 28
CE stands for conjugated estrogens.
MPA stands for medroxyprogesterone acetate.
Vaginal and vulvar dryness and thinning from menopause
Women with a uterus, taking Prempro A single tablet to be taken orally once daily
Good to know
When prescribing solely for this condition, topical vaginal products should be considered
Women with a uterus, taking Premphase Dose 0.625 mg daily
- One maroon 0.625 mg CE tablet taken daily on days 1 through 14 and one light-blue tablet containing 0.625 mg CE and 5 mg MPA taken on days 15 through 28
Good to know
When prescribing solely for this condition, topical vaginal products should be considered
CE stands for conjugated estrogens.
MPA stands for medroxyprogesterone acetate.
Preventing bone loss (osteoporosis) after menopause
Women with a uterus, taking Prempro A single tablet to be taken orally once daily
Good to know
Therapy should only be considered for women at significant risk of osteoporosis when prescribing solely for prevention
Women with a uterus, taking Premphase Dose 0.625 mg daily
- One maroon 0.625 mg CE tablet taken daily on days 1 through 14 and one light-blue tablet containing 0.625 mg CE and 5 mg of MPA taken on days 15 through 28
Good to know
Therapy should only be considered for women at significant risk of osteoporosis when prescribing solely for prevention
CE stands for conjugated estrogens.
MPA stands for medroxyprogesterone acetate.
Side Effects
The most common side effects in clinical studies were:
Common side effects
- Breast pain or tenderness
- Headache
- Abdominal pain
- Nausea and gas
- Back pain
- Depression or mood changes
- Itching
- Vaginal bleeding or spotting
- Weakness (asthenia)
- Painful periods and vaginal discharge
When to get medical help
- Call emergency services for sudden chest pain, trouble breathing, or signs of a stroke.
- Get help for leg pain or swelling, which can signal a blood clot (DVT) in the leg or lung (PE).
- Seek help right away for sudden partial or complete loss of vision, double vision, bulging eyes, or sudden migraine.
- Tell your doctor about unexplained or recurring vaginal bleeding after menopause.
- Report new breast lumps or other breast changes.
- Call your doctor for yellowing of the skin or eyes (cholestatic jaundice).
- Tell your doctor about memory problems or confusion.
Serious reactions include blood clots, stroke, heart attack, vision loss and jaundice. Get medical help right away if these occur.
Warnings and Precautions
- Boxed warning: raised risk of blood clots, stroke, heart attack, invasive breast cancer and probable dementia.
- Not for preventing heart disease or dementia.
- Gallbladder disease risk is 2 to 4 times higher.
- Severe high calcium can occur in women with breast cancer that has spread to bone.
- Stop and call your doctor for sudden vision loss, double vision, bulging eyes or sudden migraine.
- Unexplained vaginal bleeding after menopause needs evaluation.
- Risk of ovarian cancer was also reported.
- Yearly breast exams and regular mammograms are important.
Interactions
Some medicines and foods change estrogen levels:
- St. John's wort, phenobarbital, carbamazepine, rifampin: may lower estrogen levels and reduce benefit.
- Erythromycin, clarithromycin, ketoconazole, itraconazole, ritonavir, grapefruit juice: may raise estrogen levels and cause more side effects.
- Aminoglutethimide: can greatly lower medroxyprogesterone absorption.
- Thyroid replacement medicine: thyroid function should be monitored.
Interactions Listed in the FDA-Approved Label
From the Conjugated Estrogens / Medroxyprogesterone prescribing information (“Drug Interactions”): what the manufacturer studied or reported to the FDA.
-
CE and MPA taken togetherWhat happensThe pharmacokinetic disposition of both drugs is not altered when they are coadministered, based on a single-dose study.
-
Inducers of CYP3A4 (St. John's wort preparations, phenobarbital, carbamazepine, rifampin)What happensMay reduce plasma concentrations of estrogens, possibly decreasing therapeutic effects and/or changing the uterine bleeding profile.
-
Inhibitors of CYP3A4 (erythromycin, clarithromycin, ketoconazole, itraconazole, ritonavir, grapefruit juice)What happensMay increase plasma concentrations of estrogens and may result in side effects.
-
AminoglutethimideWhat happensGiven with MPA, it may significantly depress the bioavailability of MPA.
Read the label’s full interactions text
7 DRUG INTERACTIONS Data from a single-dose drug-drug interaction study involving CE and MPA indicate that the pharmacokinetic disposition of both drugs is not altered when the drugs are coadministered. No other clinical drug-drug interaction studies have been conducted with CE plus MPA. • Inducers and/or inhibitors of CYP3A4 may affect estrogen drug metabolism • Aminoglutethimide administered concomitantly with MPA may significantly depress the bioavailability of medroxyprogesterone acetate 7.1 Metabolic Interactions In vitro and in vivo studies have shown that estrogens are metabolized partially by cytochrome P450 3A4 (CYP3A4). Therefore, inducers or inhibitors of CYP3A4 may affect estrogen drug metabolism. Inducers of CYP3A4, such as St. John's wort ( Hypericum perforatum ) preparations, phenobarbital, carbamazepine, and rifampin, may reduce plasma concentrations of estrogens, possibly resulting in a decrease in therapeutic effects and/or changes in the uterine bleeding profile. Inhibitors of CYP3A4, such as erythromycin, clarithromycin, ketoconazole, itraconazole, ritonavir and grapefruit juice, may increase plasma concentrations of estrogens and may result in side effects. Aminoglutethimide administered concomitantly with MPA may significantly depress the bioavailability of MPA.
Not a complete list. The label covers the interactions the manufacturer studied or reported, and our own interaction database does not cover every medicine either. Bring your full medication list, including vitamins and herbal products, to your pharmacist.
Before You Start
- Do not use with undiagnosed abnormal vaginal bleeding.
- Do not use with breast cancer, a history of it, or estrogen-dependent cancers.
- Do not use with active or past blood clots, stroke or heart attack.
- Do not use with liver disease.
- Do not use with clotting disorders such as protein C, protein S or antithrombin deficiency.
- Do not use with a prior severe allergic reaction to it.
- Not for use in pregnancy or in children.
- Breastfeeding: it can reduce milk production.
- Older adults: higher risks of dementia, stroke and breast cancer in studies.
- Kidney and liver effects on the drug have not been studied.
Overdose
Too much may cause nausea, vomiting, breast tenderness, abdominal pain, drowsiness and fatigue. Withdrawal bleeding may occur. Treatment is to stop the medicine and provide symptom care.
How Your Body Processes It
Both hormones are well absorbed from the digestive tract. In Prempro the estrogens are released slowly over several hours, while medroxyprogesterone is released right away. Taking it with food changes peak levels of some components, and about doubles the peak of medroxyprogesterone. Estrogens spread widely through the body and are largely bound to proteins in the blood. Estrogens are partly broken down by the CYP3A4 enzyme.
Storage
Store at 20° to 25°C (68° to 77°F); excursions permitted to 15° to 30°C (59° to 86°F) .
Written from the FDA-approved label with AI and reviewed by our pharmacy team. How we use AI
Conjugated Estrogens / Medroxyprogesterone: Pharmacist Answers to Common Questions
Quick, plain-English answers to the questions patients ask most about Conjugated Estrogens / Medroxyprogesterone — the kind of thing our pharmacy team would talk through with you at the counter.
What is Prempro used for?
How do I take Prempro?
What side effects should I expect?
Is Prempro safe? What are the main risks?
Can I take it with grapefruit juice or other medicines?
Can I take Prempro if I'm pregnant or breastfeeding?
Is conjugated estrogens / medroxyprogesterone available over the counter?
When was conjugated estrogens / medroxyprogesterone first available?
What is the brand name of conjugated estrogens / medroxyprogesterone?
What is the generic name of Prempro?
What drug class is conjugated estrogens / medroxyprogesterone?
What strengths does conjugated estrogens / medroxyprogesterone come in?
How much does conjugated estrogens / medroxyprogesterone cost?
Where can I read the conjugated estrogens / medroxyprogesterone prescribing information (package insert)?
Answers drafted from the FDA-approved label with AI and reviewed by our pharmacy team. How we use AI
Ask Anything About Conjugated Estrogens / Medroxyprogesterone
Skip the scrolling. Ask in your own words and get an answer from Conjugated Estrogens / Medroxyprogesterone’s FDA label and our pharmacists’ own work.
Name another drug or a supplement in your question and we check both.
AI answers from FDA labels and our own records, never the open internet. AI can make mistakes, so always check with your doctor or pharmacist.How this works
- Sources: Conjugated Estrogens / Medroxyprogesterone’s FDA label, including the clinical studies it reports, and the label of any drug you name; our pharmacists’ own work, such as our Do Not Crush list and our published answers to readers’ questions; our pharmacy prices and the Natural Medicines supplement database.
- Written by AI: Answers are written by AI from those sources, and AI can make mistakes. Check what you read here with your doctor or pharmacist before you act on it.
- Reviewed afterward: Our pharmacy team reviews every question and answer afterward to check it for accuracy, and when we find an error, we correct how the box answers. Read more in How we use AI.
- Not medical advice. In an emergency, call 911, Poison Control at 1-800-222-1222, or 988.
More About Conjugated Estrogens / Medroxyprogesterone on HelloPharmacist
Still have a question? A licensed pharmacist answers for free, as soon as they can.Conjugated Estrogens / Medroxyprogesterone Forms and Strengths (How It Comes)
Conjugated Estrogens / Medroxyprogesterone comes in 1 dose form, the tablet. Different forms and brands can have different approved uses, doses, schedules, and directions. Follow the instructions for your exact product, and do not switch forms without guidance from your prescriber or pharmacist.
Need a version that does not list lactose, a gluten source, a dye or gelatin? Inactive ingredients differ by manufacturer: see Conjugated Estrogens / Medroxyprogesterone inactive ingredients by manufacturer.
Tablet
How this form is used
- Prempro treats moderate to severe hot flashes and night sweats due to menopause in women with a uterus.
- Prempro treats moderate to severe vulvar and vaginal atrophy due to menopause.
- Prempro helps prevent postmenopausal osteoporosis.
- Prempro is one tablet taken by mouth once daily.
- Prempro should be used at the lowest effective dose for the shortest duration that fits your treatment goals.
Conjugated Estrogens / Medroxyprogesterone on the U.S. Market: Products, Makers and Brands
How Conjugated Estrogens / Medroxyprogesterone appears in the FDA’s National Drug Code Directory — including its dosage forms, strengths, brand names, manufacturers, and FDA-listed product records. These are directory records, not sales or prescription volume.
1 company lists 5 Conjugated Estrogens / Medroxyprogesterone product records with the FDA, mostly as tablet; the earliest marketing or approval year on record is 2003. Brand names in the directory today include Prempro and Premphase; the rest are generics.
Also listed with the FDA, not a patient dose form: Unfinished tablet, sugar coated (4) · Kit (1) — bulk drug substance and unfinished product sold to compounders and other manufacturers to finish, and multi-item kits. These aren’t counted in the dose-form total above.
How Widely Conjugated Estrogens / Medroxyprogesterone Is Used (Medicaid Data)
How many Conjugated Estrogens / Medroxyprogesterone prescriptions Medicaid paid for in Q2 2025 – Q1 2026, every brand, strength and form together. Medicaid is one program, so total U.S. use is higher.
How commonly is Conjugated Estrogens / Medroxyprogesterone prescribed? Of the 1,682 medications we measure, Conjugated Estrogens / Medroxyprogesterone ranks #648 by Medicaid prescriptions — more than 61% of them.
Source: Medicaid State Drug Utilization Data (CMS), all states. 5 of the 9 listed Conjugated Estrogens / Medroxyprogesterone NDCs had Medicaid claims.
Compare Conjugated Estrogens / Medroxyprogesterone Products
A representative set of FDA-listed product records for Conjugated Estrogens / Medroxyprogesterone — across manufacturers, strengths, and dosage forms, grouped by form with each product’s manufacturer and how the FDA approved it. The same medicine may be made and packaged by different companies, so a single drug can have many directory entries. (It’s also why a refill can look different — a new shape, color, or box — even though it contains the same medication.)
| Strength | Route | Manufacturer / Labeler | Category ⓘ | Details |
|---|---|---|---|---|
| 💊Tablet | ||||
| ESTROGENS, CONJUGATED 0.3 mg/1; MEDROXYPROGESTERONE ACETATE 1.5 mg | Oral | Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc. | NDA | View NDC → |
| ESTROGENS, CONJUGATED 0.45 mg/1; MEDROXYPROGESTERONE ACETATE 1.5 mg | Oral | Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc. | NDA | View NDC → |
| ESTROGENS, CONJUGATED 0.625 mg/1; MEDROXYPROGESTERONE ACETATE 2.5 mg | Oral | Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc. | NDA | View NDC → |
| ESTROGENS, CONJUGATED 0.625 mg/1; MEDROXYPROGESTERONE ACETATE 5 mg | Oral | Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc. | NDA | View NDC → |
| 💊Kits | ||||
| — | — | Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc. | NDA | View NDC → |
Showing 5 of 5 products — FDA National Drug Code Directory. See every product, package size and price: browse all 5 Conjugated Estrogens / Medroxyprogesterone NDCs →
Conjugated Estrogens / Medroxyprogesterone Side Effects Reported to the FDA (FAERS)
After a medicine reaches the market, patients, doctors and drugmakers can send the FDA reports of problems they think may be linked to it. Here’s what’s been reported for Conjugated Estrogens / Medroxyprogesterone — a signal of what to watch for, not proof the drug caused it.
Source: openFDA, from the FDA Adverse Event Reporting System (FAERS). These are voluntary reports — they don’t prove the drug caused the effect, and counts reflect how often something was reported, not how often it actually happens. Reports also often name the very problem the medicine is taken for — a common reason to file one is that the drug didn’t help — so for a pain reliever you may see “pain” high on the list; that points to why the report was filed, not to the drug causing the symptom. This counts every report that lists Conjugated Estrogens / Medroxyprogesterone in any role, so the total runs higher than the FDA’s official dashboard, which counts only cases where the drug is the suspect. For the authoritative figures, see the FDA FAERS Public Dashboard. Always talk to your pharmacist or doctor.
Conjugated Estrogens / Medroxyprogesterone FDA Approval History
How Conjugated Estrogens / Medroxyprogesterone went from FDA review to the pharmacy shelf — the key milestones in its regulatory journey.
Source: Drugs@FDA.
Conjugated Estrogens / Medroxyprogesterone Recall History
A recall is when a specific batch of a medicine is pulled from the market — usually a manufacturing issue, not a problem with the drug itself. Class I is most serious, Class III least.
The FDA’s enforcement reports list no Conjugated Estrogens / Medroxyprogesterone recalls since July 2021.
✅No Conjugated Estrogens / Medroxyprogesterone recalls on record since July 2021Source: FDA enforcement (recall) reports, via openFDA; our copy was last updated Nov 19, 2026.
Conjugated Estrogens / Medroxyprogesterone Supply and Shortage Status
Whether Conjugated Estrogens / Medroxyprogesterone is in short supply in the U.S. right now, plus any shortage history the FDA has on record. A shortage usually reflects a manufacturing or demand issue — not a safety problem with the drug.
Source: openFDA, from the FDA Drug Shortages database.
What Conjugated Estrogens / Medroxyprogesterone Costs Pharmacies (NADAC Benchmark)
What pharmacies pay to buy Conjugated Estrogens / Medroxyprogesterone: the national average from CMS’s weekly NADAC survey, as of Nov 18, 2026. It is the pharmacy’s cost, not your price at the counter.
How the Pharmacy Price Has Changed
Pick a strength to see how its price has changed since Nov 2023.
For brand-name Prempro, the ESTROGENS, CONJUGATED 0.3 mg/1; MEDROXYPROGESTERONE ACETATE 1.5 mg tablet, pharmacies paid an average of $8.68 per tablet as of Nov 18, 2026, up 2.6% from $8.46 a year earlier.
- What pharmacies pay now
- $8.68
- per tablet, as of Nov 18, 2026
- Last 4 weeks
- No change
- from $8.68 on Oct 21, 2026
- Last 12 months
- Up 2.6%
- from $8.46 on Nov 19, 2025
- Lowest and highest since Nov 2023
- $8.03 to $8.69
- per tablet
See the numbers, month by month
| Month | Pharmacy price |
|---|---|
| Nov 2026 | $8.68 |
| Oct 2026 | $8.68 |
| Sep 2026 | $8.68 |
| Aug 2026 | $8.68 |
| Jul 2026 | $8.68 |
| Jun 2026 | $8.68 |
| May 2026 | $8.68 |
| Apr 2026 | $8.69 |
| Mar 2026 | $8.69 |
| Feb 2026 | $8.69 |
| Jan 2026 | $8.69 |
| Dec 2025 | $8.69 |
| Nov 2025 | $8.46 |
| Oct 2025 | $8.46 |
| Sep 2025 | $8.47 |
| Aug 2025 | $8.46 |
| Jul 2025 | $8.46 |
| Jun 2025 | $8.46 |
| May 2025 | $8.47 |
| Apr 2025 | $8.48 |
| Mar 2025 | $8.48 |
| Feb 2025 | $8.48 |
| Jan 2025 | $8.48 |
| Dec 2024 | $8.28 |
| Nov 2024 | $8.29 |
| Oct 2024 | $8.29 |
| Sep 2024 | $8.29 |
| Aug 2024 | $8.29 |
| Jul 2024 | $8.29 |
| Jun 2024 | $8.29 |
| May 2024 | $8.29 |
| Apr 2024 | $8.27 |
| Mar 2024 | $8.27 |
| Feb 2024 | $8.27 |
| Jan 2024 | $8.27 |
| Dec 2023 | $8.03 |
| Nov 2023 | $8.03 |
| Form | Strength | Version | What pharmacies pay | |
|---|---|---|---|---|
| Tablet · Oral | ESTROGENS, CONJUGATED 0.3 mg/1; MEDROXYPROGESTERONE ACETATE 1.5 mg | Prempro (brand) | $8.68 per tablet | NDC details & price history |
| Tablet · Oral | ESTROGENS, CONJUGATED 0.45 mg/1; MEDROXYPROGESTERONE ACETATE 1.5 mg | Prempro (brand) | $8.68 per tablet | NDC details & price history |
| Tablet · Oral | ESTROGENS, CONJUGATED 0.625 mg/1; MEDROXYPROGESTERONE ACETATE 2.5 mg | Prempro (brand) | $8.67 per tablet | NDC details & price history |
| Tablet · Oral | ESTROGENS, CONJUGATED 0.625 mg/1; MEDROXYPROGESTERONE ACETATE 5 mg | Prempro (brand) | $8.67 per tablet | NDC details & price history |
Source: CMS National Average Drug Acquisition Cost (NADAC). Each row spans the package sizes CMS priced; the generic and the brand are priced separately.
Conjugated Estrogens / Medroxyprogesterone Brand Names
Conjugated Estrogens / Medroxyprogesterone has 2 brand names on record: Prempro and Premphase. A brand name is one company's name for the medicine; a generic has the same active ingredient under its generic name.
Who Makes Conjugated Estrogens / Medroxyprogesterone: Manufacturers and Labelers
One company lists Conjugated Estrogens / Medroxyprogesterone products with the FDA. By number of product records, the largest are Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.. Labelers include manufacturers and repackagers; the product in your bottle depends on which one your pharmacy stocks.
Sources for This Conjugated Estrogens / Medroxyprogesterone Page
Core label, product, RxNorm, safety, and utilization data on this page come from the sources identified below. AI-written, editorial, and licensed sections are labeled separately.
How this page is built
HelloPharmacist combines public FDA and NLM records and does not author the underlying clinical facts. The plain-language sections are written with AI from the FDA-approved label text and reviewed by our pharmacy team before publication. Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc. is the representative DailyMed label linked for verification and dates. This is general education, not medical advice: always talk to your doctor or pharmacist about your own medicines. How we build and review drug pages →